Alyeska Investment Group, L.P. Syndax Pharmaceuticals Inc Transaction History

Alyeska Investment Group, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$20.64 - $26.24 $2.06 Million - $2.62 Million	100,000 New	100,000 $2.55 Million
Q2 2018 Aug 14, 2018	BUY	$6.93 - $14.63 $75,079 - $158,501	10,834 Added 3.3%	338,789 $2.38 Million
Q1 2018 May 15, 2018	SELL	$8.71 - $14.82 $25,738 - $43,793	-2,955 Reduced 0.89%	327,955 $4.67 Million
Q3 2017 Nov 14, 2017	BUY	$10.9 - $12.73 $3.61 Million - $4.21 Million	330,910	330,910 $3.87 Million

228

89.9M

1.01M

692K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $802M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.